Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2014 - 2026)
Amphastar Pharmaceuticals' (AMPH) quarterly Exchange Rate Effect came in at -$138000.0 in Q1 2026, down 216.95% year-on-year from $118000.0 in Q1 2025, and down 1433.33% quarter-over-quarter from -$9000.0 in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Exchange Rate Effect history runs 13 years deep, the most recent figure standing at -$138000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 216.95% year-over-year to -$138000.0 in Q1 2026; TTM through Mar 2026 was -$46000.0, a 284.0% decrease from a year earlier, with the FY2025 full-year figure at $210000.0, up 210.53% from the prior year.
- Exchange Rate Effect declined to -$138000.0 in Q1 2026 per AMPH's latest filing, from -$9000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $142000.0 in Q2 2025 and bottomed at -$238000.0 in Q4 2023.
- The 5-year median for Exchange Rate Effect is -$29000.0 (2022), against an average of -$36470.6.
- Across the five-year window, Exchange Rate Effect sank 1352.63% in 2023 and soared 847.37% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $19000.0 in 2022, then sank by 1352.63% to -$238000.0 in 2023, then soared by 95.38% to -$11000.0 in 2024, then increased by 18.18% to -$9000.0 in 2025, then tumbled by 1433.33% to -$138000.0 in 2026.
- Per Business Quant, the three latest AMPH Exchange Rate Effect figures stand at -$138000.0 (Q1 2026), -$9000.0 (Q4 2025), and -$41000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Amphastar Pharmaceuticals | 855.23 Mn | 684.09 Mn | 70.32 Mn | -138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -138,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Sep 30, 2024 | -63,000.00 |
| Sep 30, 2024 | -63,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | -97,000.00 |
| Mar 31, 2024 | -97,000.00 |
| Dec 31, 2023 | -238,000.00 |
| Dec 31, 2023 | -238,000.00 |